APA (7th ed.) Citation

Gaykema, S. B., Jong, J. R. d., Perik, P. J., Brouwers, A. H., Schröder, C. P., Munnink, T. H. O., . . . Hooge, M. N. L. In-Trastuzumab Scintigraphy in HER2-Positive Metastatic Breast Cancer Patients Remains Feasible during Trastuzumab Treatment. SAGE Publishing.

Chicago Style (17th ed.) Citation

Gaykema, Sietske B.M., Johan R. de Jong, Patrick J. Perik, Adrienne H. Brouwers, Carolien P. Schröder, Thijs H. Oude Munnink, Alphons H.H Bongaerts, Elisabeth G.E. de Vries, and Marjolijn N. Lub-de Hooge. In-Trastuzumab Scintigraphy in HER2-Positive Metastatic Breast Cancer Patients Remains Feasible During Trastuzumab Treatment. SAGE Publishing.

MLA (9th ed.) Citation

Gaykema, Sietske B.M., et al. In-Trastuzumab Scintigraphy in HER2-Positive Metastatic Breast Cancer Patients Remains Feasible During Trastuzumab Treatment. SAGE Publishing.